Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News


July 31, 2013
Rectal STIs Raise Risk of HIV Infection Among Gay Men
Gay men who are diagnosed with a rectal sexually transmitted infection (STI) are much more likely to subsequently acquire HIV.
July 30, 2013
No Improvement in Survival of HIV-Related Lymphoma
Mortality rates for those diagnosed with HIV-related lymphoma have remained flat during the modern era of antiretrovirals. 
July 29, 2013
CDC Raises Alarm that HPV Vaccine Is ‘Grossly Underutilized’
Only a third of American teenage girls 13 to 17 were fully vaccinated against human papillomavirus virus (HPV) in 2012, a small decline from 2011.
July 26, 2013
Gut Bacteria May Cause Inflammation, Aggravate HIV Disease
Intestinal bacteria of people with HIV may perpetuate the body’s initial inflammatory immune response to the virus and account for various chronic diseases.
Gay Men Often Enjoy, But Also Worry About, Bareback Porn
Gay men frequently have an affinity for barebacking porn, but their enjoyment is often tempered by their concerns that it may influence their sexual risk-taking.
July 24, 2013
Congress Closer to Lifting HIV-Positive Organ Donor Ban
A U.S. House of Representatives committee has unanimously approved a bill that would remove the ban on HIV-positive organ donors.
July 22, 2013
Post-Cure Hep C Reinfection Is Common Among Prisoners
Prisoners who achieve a cure for hepatitis C virus (HCV) are at high risk for reinfection, especially if they continue to inject drugs on the inside. 
Hep B or C Coinfection Spells Worse Response to HIV Meds
People with HIV who are coinfected with either hepatitis B or C experience diminished response to  treatment for HIV and have a greater risk of death.
58% of European Gay Men Report Condomless Sex
Twenty-six percent of European gay men reported unprotected sex with a casual partner in the past year, and 39 percent reported it with a casual partner.
Quad Pill Measures Up to Two Other HIV Drug Regimens
The single-pill, once-daily antiretroviral therapy Stribild, also known as the “Quad” pill, is as effective as both Atripla and a Reyataz plus Truvada combo.
Victrelis Ups Hep C Cure Rates in Those Coinfected With HIV
Victrelis, when added to interferon and ribavirin, improves cure rates of hepatitis C and does not raise major treatment risks in those coinfected with HIV.
July 19, 2013
Boy With HIV and Leukemia Dies After Cord Blood Transplant
A 12-year-old boy with HIV and leukemia has died after undergoing the first-ever attempt to cure both diseases with a cord-blood transplant.
Statins Take Bite Out of Cancer Risk in People With HIV
Taking statins nearly cuts in half the risk of developing cancer among people with HIV.
July 18, 2013
HIV’s Power Harnessed for Good in New Gene Therapies
HIV has a new role in cutting-edge genetic therapies in which the virus is rendered harmless but retains the power to infect cells and introduce genetic code.
Making It Official: HIV Meds Have Improved Vastly
During the history of HIV, clinical trials of antiretrovirals have charted a steady, upward climb in efficacy, according to a large meta-analysis.
Lower Dose of Kaletra Works Well for Kids With HIV
Cutting the standard dose of Kaletra by 30 percent does not change its efficacy at suppressing HIV and it improves abnormal lipid levels among children.
HPV Vaccine Could Reduce Anal Cancer Rates in Older Gay Men
Human papillomavirus (HPV) vaccines, given to older gay men, could prevent the transmission of strains of the virus that lead to anal cancer.
July 17, 2013
Negative Gay Men Consider Viral Load Before Unprotected Sex
HIV-negative gay men are much less likely to engage in unprotected intercourse with an positive partner if they perceive him to have a detectable viral load.
Once-a-Month HIV Meds Show Promise in Early Trial
Two long-acting HIV meds maintained adequate blood levels and exhibited a promising safety profile when given to HIV-negative participants in an early trial.
Viral Shedding May Occur in Semen Despite Undetectable Status
One in 13 HIV-positive gay men who maintain an undetectable blood viral load still experience intermittent viral shedding in their semen.
July 16, 2013
A 15-Year Jump in Life Expectancy for People With HIV
American and Canadians with treated HIV enjoyed an increase in life expectancy of 15 years between the periods of 2000 to 2002 and 2006 to 2007.
Two New Therapies Successfully Treat Gonorrhea
The CDC and the NIH have announced that two new antibiotic therapies are highly effective at treating gonorrhea. 
July 15, 2013
Numerous Studies Show Benefit of Earlier HIV Treatment
Pooled evidence shows that treating HIV when CD4 cells are at or above 350 is beneficial when compared with beginning therapy between 200 and 349 CD4s.
People With HIV Have High Rates of End-Stage Renal Disease
People with HIV have a rate of end-stage renal disease (ESRD) more than five times that of the general population,
July 12, 2013
Lottery Incentives Slash HIV Risk for Women in Lesotho
Offering lottery tickets to those who remained free of STI's reduced by a third the number of new HIV infections among young women in Lesotho.
Hot Flashes Are a Bigger Drag on Women With HIV
Women living with HIV suffer from more intense hot flashes than those without the virus, with symptoms taking a more significant toll.
A Reduced Dose of Sustiva Proves Successful
Sustiva (efavirenz) is both safe and just as effective at fighting HIV when the standard dose is reduced by a third.
July 11, 2013
Battle of the Integrase Inhibitors: Dolutegravir Bests Isentress
Given to HIV-positive people who are treatment-experienced, the investigational integrase inhibitor dolutegravir has proved superior to Isentress.
A Sustiva Trip? The HIV Med and LSD are Fellow Hallucinogens
LSD, Sustiva, efavirenz, neuropsychiatric side effects, Neuropsychopharmacalogy, hallucinogenic.
July 10, 2013
Acute HIV Symptoms Predict Disease Progression
Worse symptoms during the earliest stage of HIV infection raise the risk of disease progression; immediate antiretroviral treatment is advised.
July 09, 2013
Number of HIV Regimens Linked to Lower Bone Mineral Density
The greater the number of times people with HIV have switched antiretroviral drug regimens, the more likely they are to have low bone mineral density.
ARVs Reduce Risk of Death After Lymphoma Diagnosis
The risk of death from HIV-related lymphoma is associated with a higher cumulative viral load during the first six months after diagnosis with the cancer.
July 08, 2013
HIV Meds Much Cheaper Globally, Unless They're Newer Drugs
Global prices for first- and second-line HIV therapies have plummeted, but newer therapies are still hugely expensive.
A Guide for Transitioning Teens Into Adult HIV Care
Pediatric HIV clinicians should instigate a well-structured plan to transition adolescent patients into adult care.
Scientists Hope to Repeat Functional Cure of ‘Mississippi Baby’
Following the apparent functional cure of a baby born to an HIV-positive mother, scientists have designed a  global trial in an attempt to repeat that success.
July 03, 2013
Tests Can't Detect HIV in Two Men After Stem Cell Transplants
There is no sign of virus in two HIV-positive people with lymphoma who received stem cell transplants and then later stopped taking their antiretrovirals.
Women With HIV Manage It Better If They’re Employed
HIV-positive women improve their ability to manage the virus if they have a job.
July 02, 2013
World Health Organization Recommends Earlier HIV Treatment
The World Health Organization now recommends  people living with HIV worldwide begin antiretroviral therapy when their CD4 count hits 500 or below.
Is Promoting Sexual Health Via Facebook ‘Weird’?
Those using Facebook to promote sexual health messages to young people must consider how youths both process information and craft an online identity.
Five-Drug Cocktail Fights HIV Reservoir During Acute Infection
Beginning a five-drug antiretroviral cocktail during the acute, or early, phase of HIV infection shows promise to fight the development of the viral reservoir.
July 01, 2013
Steroid Injections Mixed With PIs Threaten Cortisol Levels
Those taking protease inhibitors and receiving corticosteroid injections are at risk for dysfunctional cortisol (stress hormone) levels.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ



Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dlw8585
    Fort Lauderdale
    Florida


    Loveladyd
    Washington
    DC


    sefarady
    New York
    California


    jap022964
    el dorado
    Arkansas
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.